Pfizer Inc (PFE) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Pfizer reported revenue of $62.58B, down 1.6% from $63.63B the year before. Net income was $7.77B (a 12.4% net margin), or $1.36 per diluted share. Gross margin was 74.3% and operating margin was 52.3%. Operating activities generated $11.70B of cash, leaving $9.07B of free cash flow. At fiscal year end, Pfizer held $208.16B in total assets against $121.39B in total liabilities, including $1.14B of cash and equivalents.
Open the full interactive Pfizer financials → Quarterly statements, key ratios, valuation history and price charts.
Pfizer Key Stats
| Share Price | $28.37 |
|---|---|
| Market Cap | $161.68B |
| P/E Ratio | 20.9 |
| Revenue YoY Growth | -1.7% |
| 52-Week Range | $22.64 – $29.02 |
| Shares Outstanding | 5.70 billion (basic, 2026 Q2) |
Pfizer Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $41.91B | $81.29B | $100.33B | $58.50B | $63.63B | $62.58B |
| Cost of Goods Sold | $8.69B | $30.82B | $34.34B | $24.95B | $17.85B | $16.07B |
| Gross Profit | $33.22B | $50.47B | $65.99B | $33.54B | $45.78B | $46.51B |
| Operating Income | $21.60B | $37.76B | $52.31B | $18.77B | $31.05B | $32.72B |
| Pre-Tax Income | $7.50B | $24.31B | $34.73B | $1.06B | $8.02B | $7.52B |
| Income Tax | $477.0M | $1.85B | $3.33B | -$1.11B | -$28.0M | -$266.0M |
| Net Income | $9.62B | $21.98B | $31.37B | $2.12B | $8.03B | $7.77B |
| Diluted EPS | $1.71 | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 |
Pfizer Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $16.65B | $17.56B | $14.45B | $15.03B |
| Net Income | $3.54B | -$1.65B | $2.69B | -$248.0M |
| Diluted EPS | $0.62 | -$0.29 | $0.47 | -$0.04 |
Pfizer Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.78B | $1.94B | $416.0M | $2.85B | $1.04B | $1.14B |
| Current Assets | $35.07B | $59.69B | $51.26B | $43.33B | $50.36B | $42.90B |
| Total Assets | $154.23B | $181.48B | $197.21B | $226.50B | $213.40B | $208.16B |
| Current Liabilities | $25.92B | $42.67B | $42.14B | $47.79B | $42.99B | $36.98B |
| Total Long-Term Debt | $39.13B | $37.64B | $35.56B | $64.25B | $60.75B | $65.00B |
| Total Liabilities | $90.76B | $104.01B | $101.29B | $137.21B | $124.90B | $121.39B |
| Shareholders' Equity | $63.24B | $77.20B | $95.66B | $89.01B | $88.20B | $86.48B |
Pfizer Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $14.40B | $32.58B | $29.27B | $8.70B | $12.74B | $11.70B |
| Cash From Investing | -$4.27B | -$22.55B | -$15.78B | -$32.28B | $2.65B | -$1.35B |
| Cash From Financing | -$9.65B | -$9.82B | -$14.83B | $26.07B | -$17.14B | -$10.30B |
| Free Cash Flow | $12.15B | $29.87B | $26.03B | $4.79B | $9.84B | $9.07B |
Figures from Pfizer's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Pfizer financials page for every line item.
Pfizer Company Profile
| Ticker | PFE |
|---|---|
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000078003 |
Frequently Asked Questions
What was Pfizer's revenue in fiscal 2025?
Pfizer (PFE) reported revenue of $62.58B for fiscal 2025.
What is Pfizer's annual revenue history?
Pfizer's annual revenue by fiscal year: 2020: $41.91B; 2021: $81.29B; 2022: $100.33B; 2023: $58.50B; 2024: $63.63B; 2025: $62.58B.
What was Pfizer's net income in fiscal 2025?
Pfizer reported net income of $7.77B for fiscal 2025.
What was Pfizer's earnings per share (EPS) in fiscal 2025?
Pfizer's diluted EPS was $1.36 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Pfizer generate in fiscal 2025?
Pfizer generated $9.07B of free cash flow in fiscal 2025.
What was Pfizer's revenue last quarter?
In its most recent reported quarter (2026 Q2), Pfizer reported revenue of $15.03B.
How much debt does Pfizer have?
Pfizer reported $65.00B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Pfizer are outstanding?
Pfizer reported a weighted average of 5.70 billion basic shares outstanding in 2026 Q2.
What is Pfizer's market cap?
Based on its latest closing price, Pfizer (PFE) has a market capitalization of about $161.68B.
When does Pfizer's fiscal year end?
Pfizer's fiscal year end, as registered with the SEC, is December 31.
Where is Pfizer headquartered?
Pfizer lists its business address in New York, New York in its SEC filings.